AR059646A1 - Compuestos analogos a los secretagogos peptidicos de la hormona de crecimiento y preparaciones que los contienen - Google Patents
Compuestos analogos a los secretagogos peptidicos de la hormona de crecimiento y preparaciones que los contienenInfo
- Publication number
- AR059646A1 AR059646A1 ARP070100806A ARP070100806A AR059646A1 AR 059646 A1 AR059646 A1 AR 059646A1 AR P070100806 A ARP070100806 A AR P070100806A AR P070100806 A ARP070100806 A AR P070100806A AR 059646 A1 AR059646 A1 AR 059646A1
- Authority
- AR
- Argentina
- Prior art keywords
- amino acids
- peptide
- thr
- leu
- gly
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 239000000122 growth hormone Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000008575 L-amino acids Chemical class 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- BGHSOEHUOOAYMY-JTZMCQEISA-N ghrelin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CN)C1=CC=CC=C1 BGHSOEHUOOAYMY-JTZMCQEISA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000000580 secretagogue effect Effects 0.000 abstract 2
- 101800001586 Ghrelin Proteins 0.000 abstract 1
- 102000012004 Ghrelin Human genes 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000013043 chemical agent Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- -1 compound amino acid Chemical class 0.000 abstract 1
- 108010051768 des-n-octanoyl ghrelin Proteins 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 238000000126 in silico method Methods 0.000 abstract 1
- 238000000302 molecular modelling Methods 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060050A CU23558A1 (es) | 2006-02-28 | 2006-02-28 | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR059646A1 true AR059646A1 (es) | 2008-04-16 |
Family
ID=40130780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070100806A AR059646A1 (es) | 2006-02-28 | 2007-02-27 | Compuestos analogos a los secretagogos peptidicos de la hormona de crecimiento y preparaciones que los contienen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8367620B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1997827B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5183496B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101409277B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101432294B (cg-RX-API-DMAC7.html) |
| AR (1) | AR059646A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007219569B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0708366A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2637593C (cg-RX-API-DMAC7.html) |
| CL (2) | CL2007000528A1 (cg-RX-API-DMAC7.html) |
| CU (1) | CU23558A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2441441T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008011142A (cg-RX-API-DMAC7.html) |
| MY (1) | MY184130A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20084118L (cg-RX-API-DMAC7.html) |
| RU (1) | RU2416618C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007098716A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200807162B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4831551B2 (ja) * | 2008-11-06 | 2011-12-07 | 国立大学法人名古屋大学 | 非虚血性心筋障害に対する医薬 |
| CU24473B1 (es) * | 2016-11-01 | 2020-02-04 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
| RU2734835C1 (ru) * | 2020-02-11 | 2020-10-23 | Федеральное государственное бюджетное учреждение науки Лимнологический институт Сибирского отделение Российской академии наук (ЛИН СО РАН) | Способ повышения жизнестойкости эмбрионов рыб в аквакультуре |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3239345A (en) | 1965-02-15 | 1966-03-08 | Estrogenic compounds and animal growth promoters | |
| US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
| JPH03502326A (ja) | 1988-01-28 | 1991-05-30 | ポリゲン ホールディング コーポレイション | 成長ホルモン放出活性を有するポリペプチド化合物類 |
| ATE122357T1 (de) | 1988-01-28 | 1995-05-15 | Polygen Holding Corp | Polypeptide mit hormonwachstumsbefreiender wirkung. |
| JP2670680B2 (ja) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
| WO1992007578A1 (en) | 1990-10-25 | 1992-05-14 | Genentech, Inc. | Use of protective agents against reactive oxygen species |
| US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| JPH08503213A (ja) | 1992-11-06 | 1996-04-09 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモンの放出を促進する置換ジペプチド同族体 |
| US5726319A (en) | 1992-11-06 | 1998-03-10 | Merck & Co., Inc. | Biphenyl substituted dipeptide analogs promote release of growth hormone |
| US5536716A (en) | 1992-12-11 | 1996-07-16 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
| CZ151495A3 (en) | 1992-12-11 | 1995-12-13 | Merck & Co Inc | Spiropiperidine derivatives, process of their preparation and a pharmaceutical composition containing thereof |
| EP0813414A4 (en) | 1993-10-19 | 1999-07-21 | Merck & Co Inc | Combination of bisphosphonates and growth hormone secretagogues |
| US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| PL322706A1 (en) | 1993-11-09 | 1998-02-16 | Merck & Co Inc | Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation |
| WO1995014666A1 (en) | 1993-11-24 | 1995-06-01 | Merck & Co., Inc. | Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
| US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
| US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| HU221092B1 (en) | 1993-12-23 | 2002-08-28 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| PT736039E (pt) | 1993-12-23 | 2001-04-30 | Novo Nordisk As | Compostos com propriedades para liberar a hormona de crescimento |
| US5777112A (en) | 1994-06-13 | 1998-07-07 | Merck & Co., Inc | Piperazine compounds promote release of growth hormone |
| WO1996002530A1 (en) | 1994-07-20 | 1996-02-01 | Merck & Co., Inc. | Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone |
| US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
| AU4495996A (en) | 1995-01-25 | 1996-08-14 | Nippon Chemiphar Co. Ltd. | Dihydrophenazine derivatives |
| DE69633003T2 (de) | 1995-01-27 | 2005-08-18 | Novo Nordisk A/S | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
| AU4534596A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO1996024587A1 (en) | 1995-02-09 | 1996-08-15 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
| AU5486396A (en) | 1995-04-19 | 1996-11-07 | Merck & Co., Inc. | Process for the preparation of spiroindolines |
| WO1996035713A1 (en) | 1995-05-08 | 1996-11-14 | Pfizer, Inc. | Dipeptides which promote release of growth hormone |
| ATE288444T1 (de) | 1995-05-29 | 2005-02-15 | Pfizer | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren |
| BR9608909A (pt) | 1995-06-22 | 1999-03-02 | Novo Nordisk As | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto |
| CA2203424A1 (en) | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamines as growth hormone secretagogues |
| EP0761220A1 (en) | 1995-08-21 | 1997-03-12 | Eli Lilly And Company | 2-Acylaminopropanamides as growth hormone secretagogues |
| EP0766966A3 (en) | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Method of treating insulin resistance |
| WO1997011697A1 (en) | 1995-09-26 | 1997-04-03 | Merck & Co., Inc. | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
| JPH11513989A (ja) | 1995-10-27 | 1999-11-30 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモン分泌促進薬の湿式造粒製剤 |
| US5723616A (en) | 1995-10-27 | 1998-03-03 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
| US5767124A (en) | 1995-10-27 | 1998-06-16 | Merck & Co., Inc. | Polymorphic forms of a growth hormone secretagogue |
| KR19990067097A (ko) | 1995-10-27 | 1999-08-16 | 폴락 돈나 엘. | 성장 호르몬 분비 촉진제의 제조 방법 |
| ES2268713T3 (es) | 1995-12-13 | 2007-03-16 | MERCK & CO., INC. | Ensayos de receptores de secretagogos de la hormona de crecimiento. |
| ATE279440T1 (de) | 1995-12-13 | 2004-10-15 | Merck & Co Inc | Wachstumshormonsekretionsförderer rezeptorfamilie |
| IT1277113B1 (it) | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
| WO1997022367A1 (en) | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Radiolabeled growth hormone secretagogue |
| IL124702A0 (en) * | 1995-12-22 | 1998-12-06 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| AU2334097A (en) | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
| WO1997036873A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
| WO1997040071A1 (en) | 1996-04-19 | 1997-10-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| EP0907643B1 (en) | 1996-04-24 | 2003-01-15 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US5919777A (en) | 1996-04-24 | 1999-07-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| CA2253390A1 (en) | 1996-05-07 | 1997-11-13 | Merck & Co., Inc. | Enhancement of sleep with a growth hormone secretagogue |
| AU2931997A (en) | 1996-05-07 | 1997-11-26 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
| WO1997043278A1 (en) | 1996-05-14 | 1997-11-20 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| US6071926A (en) | 1996-05-22 | 2000-06-06 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
| PL330239A1 (en) | 1996-05-31 | 1999-05-10 | Novo Nordisk As | Growt hormone constituent and bone reserption preventing factor in cyclic (coherent) treatment |
| AU3434697A (en) | 1996-07-22 | 1998-02-10 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU4342097A (en) | 1996-09-13 | 1998-04-02 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| AU4993497A (en) | 1996-10-25 | 1998-05-22 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
| SE9703929D0 (sv) | 1996-11-22 | 1997-10-28 | Pharmacia & Upjohn Ab | Therapeutical use and method |
| AU6747498A (en) | 1997-04-11 | 1998-11-11 | Sumitomo Pharmaceuticals Company, Limited | Benzene derivatives |
| JP2000514838A (ja) | 1997-05-14 | 2000-11-07 | 藤沢薬品工業株式会社 | 成長ホルモンの放出を促進するピペリジノ誘導体 |
| US5861149A (en) | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
| EP1005484A1 (en) | 1997-06-20 | 2000-06-07 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| UA53716C2 (uk) | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
| WO1998058947A1 (en) | 1997-06-25 | 1998-12-30 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
| UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
| ZA987383B (en) | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
| DE69836386T2 (de) | 1997-08-22 | 2007-10-11 | Kaken Pharmaceutical Co., Ltd. | Amide zur Förderung der Ausschüttung von Wachstumshormonen |
| IL137007A0 (en) | 1998-01-16 | 2001-06-14 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| WO1999039730A1 (en) | 1998-02-09 | 1999-08-12 | Kaken Pharmaceutical Co., Ltd. | Oral preparations containing peptides promoting the secretion of growth hormone |
| HUP0100998A3 (en) | 1998-03-03 | 2001-12-28 | Novo Nordisk As | (2e)-5-amino-5-methylhex-2-enoic acid n-methyl-n-((1r)-1-(n-methyl-n-((1r)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphtyl)ethyl)amide salts, methods for their preparation, pharmaceutical compositions comprising thereof and their use |
| PL194560B1 (pl) | 1998-05-11 | 2007-06-29 | Novo Nordisk As | Związki o właściwościach uwalniania hormonu wzrostu, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie |
| JP4574849B2 (ja) | 1998-06-09 | 2010-11-04 | サファイア セラピューティクス，インコーポレイティド | 成長ホルモン放出特性を有する化合物を調製するための方法 |
| HN1999000097A (es) | 1998-06-16 | 1999-11-03 | Pfizer Prod Inc | Terapia de combinacion para la fragilidad muscoloesqueletica |
| KR20010052817A (ko) | 1998-06-16 | 2001-06-25 | 실버스타인 아써 에이. | 근골격 무름을 치료하기 위한 선택적인 에스트로겐 수용체조절제 및 성장 호르몬 분비촉진제의 치료적 혼합물 |
| CA2334315C (en) | 1998-06-30 | 2011-07-26 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| KR100680085B1 (ko) | 1998-08-20 | 2007-02-28 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 성장호르몬 방출촉진제로서 옥신돌 유도체 |
| US6358951B1 (en) | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
| AU2405401A (en) | 1999-12-28 | 2001-07-09 | Kaken Pharmaceutical Co., Ltd. | Nerve protective drugs |
| CA2411667A1 (en) | 2000-05-30 | 2001-12-06 | Merck & Co. Inc. | Ghrelin analogs |
| ES2333097T3 (es) | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal. |
| CN1232507C (zh) | 2000-06-13 | 2005-12-21 | 曾塔里斯股份公司 | 生长激素促分泌剂 |
| EP1297839A4 (en) | 2000-06-23 | 2005-12-07 | Kaken Pharma Co Ltd | PREVENTIVA OR THERAPEUTIC AGAINST HEART FAILURE |
| ITMI20011445A1 (it) | 2001-07-06 | 2003-01-06 | Europ Geie | Analoghi della cortistantina capaci di legarsi selettivamente ai recettori dei secretagoghi dell'ormone della crescita |
| CU23043A1 (es) | 2001-12-20 | 2005-05-20 | Ct Ingenieria Genetica Biotech | Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico. |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| WO2005039625A1 (en) | 2003-10-28 | 2005-05-06 | Rheoscience A/S | Growth hormone secretagogue receptor agonists |
| EP1682136A4 (en) | 2003-11-04 | 2009-06-03 | Elixir Pharmaceuticals Inc | THERAPEUTIC COMPOUNDS AND CORRESPONDING USES THEREOF |
| WO2005048916A2 (en) | 2003-11-20 | 2005-06-02 | Biovitrum Ab | Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
-
2006
- 2006-02-28 CU CU20060050A patent/CU23558A1/es active IP Right Grant
-
2007
- 2007-02-27 AR ARP070100806A patent/AR059646A1/es not_active Application Discontinuation
- 2007-02-27 CL CL2007000528A patent/CL2007000528A1/es unknown
- 2007-02-28 BR BRPI0708366-1A patent/BRPI0708366A2/pt not_active IP Right Cessation
- 2007-02-28 CN CN2007800153594A patent/CN101432294B/zh not_active Expired - Fee Related
- 2007-02-28 MY MYPI20083178A patent/MY184130A/en unknown
- 2007-02-28 KR KR1020087023543A patent/KR101409277B1/ko not_active Expired - Fee Related
- 2007-02-28 AU AU2007219569A patent/AU2007219569B2/en not_active Ceased
- 2007-02-28 US US12/281,085 patent/US8367620B2/en not_active Expired - Fee Related
- 2007-02-28 CA CA2637593A patent/CA2637593C/en not_active Expired - Fee Related
- 2007-02-28 RU RU2008138569/10A patent/RU2416618C2/ru not_active IP Right Cessation
- 2007-02-28 ES ES07711101.1T patent/ES2441441T3/es active Active
- 2007-02-28 WO PCT/CU2007/000007 patent/WO2007098716A1/es not_active Ceased
- 2007-02-28 MX MX2008011142A patent/MX2008011142A/es active IP Right Grant
- 2007-02-28 JP JP2008556643A patent/JP5183496B2/ja not_active Expired - Fee Related
- 2007-02-28 EP EP07711101.1A patent/EP1997827B1/en not_active Not-in-force
-
2008
- 2008-08-19 ZA ZA200807162A patent/ZA200807162B/xx unknown
- 2008-09-29 NO NO20084118A patent/NO20084118L/no not_active Application Discontinuation
-
2016
- 2016-06-24 CL CL2016001648A patent/CL2016001648A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200807162B (en) | 2009-06-24 |
| CU23558A1 (es) | 2010-07-20 |
| CA2637593A1 (en) | 2007-09-07 |
| JP2009528303A (ja) | 2009-08-06 |
| BRPI0708366A2 (pt) | 2011-05-24 |
| RU2416618C2 (ru) | 2011-04-20 |
| KR20080110763A (ko) | 2008-12-19 |
| WO2007098716A8 (es) | 2008-12-18 |
| CA2637593C (en) | 2015-04-14 |
| US8367620B2 (en) | 2013-02-05 |
| MX2008011142A (es) | 2008-09-08 |
| AU2007219569B2 (en) | 2012-03-15 |
| CN101432294A (zh) | 2009-05-13 |
| WO2007098716A1 (es) | 2007-09-07 |
| CL2016001648A1 (es) | 2017-02-24 |
| NO20084118L (no) | 2008-09-29 |
| ES2441441T3 (es) | 2014-02-04 |
| EP1997827B1 (en) | 2013-10-09 |
| CL2007000528A1 (es) | 2008-01-18 |
| KR101409277B1 (ko) | 2014-06-24 |
| AU2007219569A1 (en) | 2007-09-07 |
| US20100055118A1 (en) | 2010-03-04 |
| EP1997827A1 (en) | 2008-12-03 |
| CN101432294B (zh) | 2013-09-11 |
| MY184130A (en) | 2021-03-19 |
| JP5183496B2 (ja) | 2013-04-17 |
| RU2008138569A (ru) | 2010-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Caporale et al. | The active site of C3a anaphylatoxin. | |
| RU2009128979A (ru) | Hla*1101-ограниченный пептид wt1 и содержащая его фармацевтическая композиция | |
| PE20121393A1 (es) | Analogo peptidico de oxintomodulina | |
| NO167866C (no) | Syntetisk peptid og preparat for tilfoersel i dyr for produksjonsfremmende formaal. | |
| MX361694B (es) | Fragmentos de peptidos para inducir sintesis de proteinas de matriz extra-celular. | |
| ME03709B (me) | Fuzijski proteini | |
| ATE442378T1 (de) | Substituierte wt1-peptide | |
| YU5396A (sh) | Novi biološki aktivni proteini, njihove farmaceutske formulacije i postupak za njihovo dobijanje | |
| NZ621868A (en) | Growth hormone polypeptides and methods of making and using same | |
| NL300013I1 (nl) | Nieuwe protein met TNF-remmende werking en hun ber | |
| EA201170337A1 (ru) | Стабильная твердая композиция полипептидного агониста gc-c рецептора, приемлемая для перорального введения | |
| NZ599161A (en) | Method for activation of helper t cell and composition for use in the method | |
| NO20053027D0 (no) | Gastrinpreparater og formuleringer, og fremgangsmater for anvendelse og fremstilling. | |
| DK413986D0 (da) | Syntetisk peptid og farmaceutisk middel indeholdende peptidet | |
| MXPA05002991A (es) | Analogos de ghrh. | |
| NZ708990A (en) | Method for activating helper t cell | |
| WO2006113681A3 (en) | Plant-derived elastin binding protein ligands and methods of using the same | |
| ES2055792T3 (es) | Compuestos analogos ciclicos a grf. | |
| KR930701483A (ko) | Grf (쥐이알에프) 유사체 xi | |
| ATE536878T1 (de) | Herstellung einer therapeutischen zusammensetzung | |
| AR059646A1 (es) | Compuestos analogos a los secretagogos peptidicos de la hormona de crecimiento y preparaciones que los contienen | |
| HUP0001431A2 (hu) | Módosított tandem peptid, ezt tartalmazó immunogén gyógyászati készítmény és vakcina az LHRH hormon termelés ellen, és eljárás a sertéshús minőségének javítására | |
| CN102160890A (zh) | 包含止痛肽的药物组合物 | |
| NO905505L (no) | Analogifremgangsmaate for fremstilling av peptider. | |
| MX2022008748A (es) | Administración oral de péptidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed, e.g., due to non-payment of fee |